Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council

https://doi.org/10.20996/1819-6446-2021-02-02

Full Text:

Abstract

The meeting of the expert council of cardiologists-lipidologists, organized with the support of Novartis and dedicated to the discussion of the existing system of medical care for patients with familial hypercholesterolemia / mixed dyslipidemia, the modern evidence base for lipid-lowering therapy and the practical value of the strategy of early combined lipid-lowering therapy for doctors and these categories of patients was held in Moscow on November 11, 2020.

About the Authors

M. V. Ezhov

Russian Federation

Marat V. Ezhov

eLibrary SPIN 7623-2135



V. V. Kukharchuk

Russian Federation

Valery V. Kukharchuk

eLibrary SPIN 6776-1083



I. V. Sergienko

Russian Federation

Igor V. Sergienko

eLibrary SPIN 1643-1586



N. M. Akhmedzhanov

Russian Federation

Nadir M. Akhmedzhanov

eLibrary SPIN 2987-9035



M. I. Voevoda

Russian Federation

Mikhail I. Voevoda

eLibrary SPIN 6133-1780



V. S. Gurevich

Russian Federation

Viktor S. Gurevich

eLibrary SPIN 3267-2301



V. V. Kashtalap

Russian Federation

Vasily V. Kashtalap

eLibrary SPIN 8816-7409



V. O. Konstantinov

Russian Federation

Vladimir O. Konstantinov

eLibrary SPIN 8720-1582



V. V. Skibitsky

Russian Federation

Vitaly V. Skibitsky

eLibrary SPIN 3595-5662



I. I. Shaposhnik

Russian Federation

Igor I. Shaposhnik

eLibrary SPIN 3184-5994



References

1. Healthcare in Russia 2019. Statistical Book Moscow: Rosstat; 2019 (In Russ.)

2. Heart and Circulatory Disease Statistics 2019. Published by the BHF in collaboration with the Institute of Applied Health Research at the University of Birmingham [cited by Jan 10, 2021]. Available from: www.bhf.org.uk/statistics.

3. State of Health in the EU. Germany. Country Health Profile 2019 [cited by Jan 10, 2021]. Available from: http://www.oecd.org/publications/germany-country-health-profile-2019-36e21650-en.htm.

4. Boytsov S.A., Shalnova S.A., Deev A.D. Mortality from cardiovascular diseases in the Russian Federation and possible mechanisms of its change. Journal of Neurology and Psychiatry. S.S. Korsakov. 2018;118(8):98-103 (In Russ.) DOI:10.17116/jnevro201811808198.

5. Boytsov S.A., Demkina A.E., Oshchepkova E.V., Dolgusheva Yu.A. Progress and Problems of Practical Cardiology in Russia at the Present Stage. Kardiologiia. 2019;59(3):53-9 (In Russ.) DOI:10.18087/cardio.2019.3.10242.

6. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Prev Med. 1986;15(3):254-73. DOI:10.1016/0091-7435(86)90045-9.

7. Cardiovascular prevention 2017. Russian national guidelines. Russian Journal of Cardiology 2018;23(6):7-122 (In Russ.) DOI:10.15829/1560-4071-2018-6-7-122.

8. 2019 ESC/EAS Guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205. DOI:10.1016/j.atherosclerosis.2019.08.014.

9. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations, VII revision. Atherosclerosis and Dyslipidemia. 2020;1:7-34 (In Russ.)

10. 2018/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol; A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350. DOI:10.1016/j.jacc.2018.11.003.

11. Methodical recommendations for the organization of medical care for patients with hereditary atherogenic disorders of lipid metabolism in the subjects of the Russian Federation. Atherosclerosis and Dyslipidemia. 2016; 4: 15-20 (In Russ.)

12. Ezhov M.V., Bliznyuk S.A., Tmoyan N.A., et al. Register of patients with familial hypercholesterolemia and patients with very high cardiovascular risk with insufficient effectiveness of lipid-lowering therapy (RENAISSANCE). Russian Journal of Cardiology. 2019;24(5):7-13 (In Russ.) DOI:10.15829/1560-4071-2019-5-7-13.


For citation:


Ezhov M.V., Kukharchuk V.V., Sergienko I.V., Akhmedzhanov N.M., Voevoda M.I., Gurevich V.S., Kashtalap V.V., Konstantinov V.O., Skibitsky V.V., Shaposhnik I.I. Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council. Rational Pharmacotherapy in Cardiology. 2021;17(1):169-172. (In Russ.) https://doi.org/10.20996/1819-6446-2021-02-02

Views: 74


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)